Daily as of 2 Nov 16:00 ET
- Price
- below both $0.77 vs 50 $1.43 / 200 $3.17
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 12 May 2026 · projected 12 bars out
CMPX | Compass TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$0.77
-$0.02 (-2.42%)
Compass Therapeutics (CMPX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $0.79 vs 50 $3.54 / 200 $2.66
- Projection
- 💀Death cross projected in 11 bars
- Test
- No active test
- Last cross
- 🟨Golden cross week of 6 Oct 2025 · projected 4 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $0.76 vs 50 $0.87 / 200 $1.78
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 25 Sep 2026 · projected 17 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 25 Sep 2026 | 💀Death | 4-hour | 17 bars out | Not tested |
| 10 Sep 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 12 May 2026 | 💀Death steep | daily | 12 bars out | Not tested |
| 31 Mar 2026 | 💀Death | 4-hour | 25 bars out | 6 bar cross test |
| week of 6 Oct 2025 | 🟨Golden moderate | weekly | 4 bars out | Not tested |
About CMPX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall